Dar Zavain 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Dar Zavain
Director
Transactions
- Award
Class A Common Stock
2026-01-02+3,571→ 142,329 total
Footnotes (1)
- [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.